Antazoline
- Generic Name
- Antazoline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H19N3
- CAS Number
- 91-75-8
- Unique Ingredient Identifier
- DHA8014SS1
- Background
Antazoline is a 1st generation antihistamine with anticholinergic activity. It is used to relieve nasal congestion. It is also formulated as eye drops with naphazoline to relieve allergic conjunctivitis.
- Indication
Used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.
- Associated Conditions
- Eye allergy
- Associated Therapies
- -
Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Centre of Postgraduate Medical Education
- Target Recruit Count
- 105
- Registration Number
- NCT05720572
- Locations
- 🇵🇱
Postgraduate Medical School, Warsaw, Poland
Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-07
- Last Posted Date
- 2015-05-22
- Lead Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Target Recruit Count
- 74
- Registration Number
- NCT01527279
- Locations
- 🇵🇱
Institute of Cardiology, II Dept. of Coronary Heart Disease, Warsaw, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath